BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe

  January 6, 2025

   · 

  4 min read
• Press Releases

  PureTech Appoints UBS as UK Corporate Broker

  January 6, 2025

   · 

  1 min read
• Press Releases

  Amgen’s IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom

  January 6, 2025

   · 

  7 min read
• Press Releases

  Nasdaq Grants Revelation Biosciences Inc. Continued Listing

  January 6, 2025

   · 

  5 min read
• Press Releases

  FDA Roundup: January 3, 2025

  January 6, 2025

   · 

  3 min read
• Press Releases

  LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy

  January 6, 2025

   · 

  3 min read
• Press Releases

  Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  January 6, 2025

   · 

  2 min read
• Press Releases

  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 3, 2025

  January 6, 2025

   · 

  4 min read
• Press Releases

  Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy

  January 6, 2025

   · 

  15 min read
• Press Releases

  NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

  January 6, 2025

   · 

  3 min read